跳至主要内容
临床试验/NCT01157598
NCT01157598Unknown3 期

Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
3 期
入组人数
56
试验地点
2
主要终点
the satisfaction of patients and endoscopist in midazolam and meperidine induced sedation with BIS monitoring during ESD

研究概览

简要总结

Background: Endoscopic submucosal dissection (ESD) usually requires adequate level of sedation due to lengthy and uncomfortable procedure. Propofol induced sedation with bispectral index (BIS) monitoring has been reported to lead to higher satisfaction of patients and endoscopists during ESD. However, there is no data about efficacy of midazolam and meperidine induced sedation with BIS monitoring during ESD. This study was to evaluate whether midazolam and meperidine induced sedation with BIS monitoring could improve the satisfaction and reduce the dose of midazolam and meperidine during ESD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • gastric adenomas, differentiated-type gastric cancers greater than 30 mm in diameter without ulceration and gastric cancers up to 30 mm with ulceration, or minute submucosal invasion

排除标准

  • if they were under 18 years of age
  • had an ASA classification of 4-5
  • were pregnant
  • had a history of stroke or an allergy to sedative drugs.

结局指标

主要结局

the satisfaction of patients and endoscopist in midazolam and meperidine induced sedation with BIS monitoring during ESD

时间窗: within the one day after ESD

次要结局

  • the dose of midazolam and meperidine during ESD with BIS monitoring(within one hour after ESD)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Efficacy of Bispectral Index Monitoring for... | 临床试验